Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients

Asian Pacific Journal of Allergy and Immunology

Volumn 29, Issue 3, 2011, Pages 290-293

  Then, Sue Mian ^a   Rani, Zam Zureena Mohd ^a   Raymond, Azman Ali ^b   Ratnaningrum, Safrina ^c   Jamal, Rahman ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^c Universiti Diponegoro   (Indonesia)

Author keywords

Carbamazepine; Drug hypersensitivity; Epilepsy; HLA B*1502 allele; Pharmacogenomics; Steve Johnson syndrome

Indexed keywords

CARBAMAZEPINE; HLA B ANTIGEN; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CHILD; CHINESE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HYPERSENSITIVITY REACTION; INFANT; MALAYSIA; MALE; PRESCHOOL CHILD; RASH; SCHOOL CHILD; STEVENS JOHNSON SYNDROME;

ADOLESCENT; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG ERUPTIONS; EPILEPSY; EXANTHEMA; FEMALE; HLA-B15 ANTIGEN; HUMANS; INFANT; MALE; MIDDLE AGED; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 80052991636     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Chung WH, Hung SI, Hong HS, Shih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Steven-Johnson syndrome. Nature. 2004;428:486.
2. Man CBL, Kwan P, Baum L, Yu E, Lau KM, Cheng ASH, et al. Association between HLA-B*1502 allele and antiepileptic druginduced cutaneous reactions in Han Chinese. Epilepsia. 2007;45:1015-8.
3. Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, et al. Carbamazepine and phenytoin induced Steven-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia. 2008;49:2087-91.
4. Chang CC, Too CL, Murad S, Hussein SH. Association of HLAB* 1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol. 2011;50:221-4.
5. Lim KS, Kwan P, Tan CT. Association of HLA-B*1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review. Neurology Asia. 2008;13:15-21.
6. Farkas R. Carbamazepine (marketed as CABATROL, EQUETRO, TEGRETOL and genericics): Stevens-Johnson syndrome, toxic epidermal necrolysis, and HLALA-B*1502. FDA Drug Safety Newsletter. 2008;1:35-7.
7. Ferrell PB, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Steven-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics. 2008;9:1543-6.